Effects of clopidogrel therapy on whole blood platelet aggregation, the Plateletworks® assay and coagulation parameters in cats with asymptomatic hypertrophic cardiomyopathy: a pilot study

References

• Brainard BM, Kleine SA, Papich MG, Budsberg SC. 2010. Pharmacodynamic and pharmacokinetic evaluation of clopidogrel and the carboxylic acid metabolite SR 26334 in healthy dogs. Am J Vet Res. 71:822–830.
   PubMed Web of Science ®Google Scholar
• Brooks M, Divers T, Watts A, Ness S, Frye A, Stokol T, Fubini S. 2013. Effects of clopidogrel on the platelet activation response in horses. Am J Vet Res. 74:1212–1222.
   PubMed Web of Science ®Google Scholar
• CAPRIE Steering Committee. 1996. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 348:1329–1339.
   PubMed Web of Science ®Google Scholar
• Cathcart C, Brainard B, Reynolds L, Al Nadaf S, Budsberg S. 2012. Lack of inhibitory effect of acetylsalicylic acid and meloxicam on whole blood platelet aggregation in cats. J Vet Emerg Crit Care. 22:99–106.
   PubMed Web of Science ®Google Scholar
• Cattaneo M. 2007. ADP receptor antagonists. In: Michelson AD, editor. Platelets. Amsterdam: Academic Press; p. 1127–1144.
   Google Scholar
• Clauss A. 1957. Rapid physiological coagulation method in determination of fibrinogen. Acta Haematol. 17:237–246.
   PubMedGoogle Scholar
• Di Castelnuovo A, Agnoli C, de Curtis A, Giurdanella MC, Sieri S, Mattiello A, Matullo G, Panico S, Sacerdote C, Tumino R, et al. 2014. Elevated levels of D-dimers increase the risk of ischaemic and haemorrhagic stroke. Findings from the EPICOR study. Thromb Haemost. 112:941–946.
   PubMed Web of Science ®Google Scholar
• Dyszkiewicz Korpanty A, Olteanu H, Frenkel E, Sarode R. 2007. Clopidogrel anti-platelet effect: an evaluation by optical aggregometry, impedance aggregometry, and the platelet function analyzer (PFA-100). Platelets. 18:491–496.
   PubMed Web of Science ®Google Scholar
• Fibrinogen Studies Collaboration, Danesh J, Lewington S, Thompson SG, Lowe GD, Collins R, Kostis JB, Wilson AC, Folsom AR, Wu K, et al. 2005. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA. 294:1799–1809.
   PubMed Web of Science ®Google Scholar
• Flechtenmacher N, Kammerer F, Dittmer R, Budde U, Michels P, Rother J, Eckert B. 2015. Clopidogrel resistance in neurovascular stenting: correlations between light transmission aggregometry, VerifyNow, and the Multiplate. Am J Neuroradiol. 36:1953–1958.
   PubMed Web of Science ®Google Scholar
• Fox PR, Liu SK, Maron BJ. 1995. Echocardiographic assessment of spontaneously occurring feline hypertrophic cardiomyopathy. an animal model of human disease. Circulation. 92:2645–2651.
   PubMed Web of Science ®Google Scholar
• Geiger J, Teichmann L, Grossmann R, Aktas B, Steigerwald U, Walter U, Schinzel R. 2005. Monitoring of clopidogrel action: comparison of methods. Clin Chem. 51:957–965.
   PubMed Web of Science ®Google Scholar
• Hamel Jolette A, Dunn M, Bédard C. 2009. Plateletworks: a screening assay for clopidogrel therapy monitoring in healthy cats. Can J Vet Res. 73:73–76.
   PubMed Web of Science ®Google Scholar
• Hansson K, Haggstrom J, Kvart C, Lord P. 2002. Left atrial to aortic root indices using two-dimensional and M-mode echocardiography in Cavalier King Charles spaniels with and without left atrial enlargement. Vet Radiol Ultrasound. 43:568–575.
   PubMed Web of Science ®Google Scholar
• Harrison P, Segal H, Silver L, Syed A, Cuthbertson FC, Rothwell PM. 2008. Lack of reproducibility of assessment of aspirin responsiveness by optical aggregometry and two platelet function tests. Platelets. 19:119–124.
   PubMed Web of Science ®Google Scholar
• Hass WK, Easton JD, Adams HP, Pryse Phillips W, Molony BA, Anderson S, Kamm B. 1989. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. ticlopidine aspirin stroke study group. N Engl J Med. 321:501–507.
   PubMed Web of Science ®Google Scholar
• Ho K, Abrams Ogg A, Wood RD, O'Sullivan ML, Kirby G, Blois S. 2016. Assessment of platelet function in healthy cats in response to commonly prescribed antiplatelet drugs using three point-of-care platelet function tests. J Feline Med Surg. doi:10.1177/1098612X16648182 [Epub 2016 May 11].
   PubMed Web of Science ®Google Scholar
• Hogan D, Andrews D, Green H, Talbott K, Ward M, Calloway B. 2004a. Antiplatelet effects and pharmacodynamics of clopidogrel in cats. J Am Vet Med Assoc. 225:1406–1411.
   PubMed Web of Science ®Google Scholar
• Hogan D, Andrews D, Talbott K, Green H, Ward M, Calloway B. 2004b. Evaluation of antiplatelet effects of ticlopidine in cats. Am J Vet Res. 65:327–332.
   PubMed Web of Science ®Google Scholar
• Hogan D, Brainard BM. 2015. Cardiogenic embolism in the cat. J Vet Cardiol. 17:S202–S214.
   PubMed Web of Science ®Google Scholar
• Hogan D, Fox PR, Jacob K, Keene B, Laste NJ, Rosenthal S, Sederquist K, Weng H. 2015. Secondary prevention of cardiogenic arterial thromboembolism in the cat: the double-blind, randomized, positive-controlled feline arterial thromboembolism; clopidogrel vs. aspirin trial (FAT CAT). J Vet Cardiol. 17:S306–S317.
   PubMed Web of Science ®Google Scholar
• Kittleson MD, Meurs KM, Munro MJ, Kittleson JA, Liu SK, Pion PD, Towbin JA. 1999. Familial hypertrophic cardiomyopathy in maine coon cats: an animal model of human disease. Circulation. 99:3172–3180.
   PubMed Web of Science ®Google Scholar
• Laste NJ, Harpster NK. 1995. A retrospective study of 100 cases of feline distal aortic thromboembolism: 1977–1993. J Am Anim Hosp Assoc. 31:492–500.
   PubMed Web of Science ®Google Scholar
• Lerner RG, Frishman WH, Mohan KT. 2000. Clopidogrel: a new antiplatelet drug. Heart Dis. 2:168–173.
   PubMedGoogle Scholar
• Mackie I, Kitchen S, Machin S, Lowe GDO. 2003. Guidelines on fibrinogen assays. Br J Haematol. 121:396–404.
   PubMed Web of Science ®Google Scholar
• Magee A, Hogan D, Sederquist K, Durham J. 2014. In vitro effects of the glycoprotein IIb/IIIa receptor antagonists abciximab and eptifibatide on platelet aggregation in healthy cats. Am J Vet Res. 75:309–312.
   PubMed Web of Science ®Google Scholar
• McGlasson DL, Fritsma GA. 2009. Whole blood platelet aggregometry and platelet function testing. Semin Thromb Hemost. 35:168–180.
   PubMed Web of Science ®Google Scholar
• Mazoyer E, Ripoll L, Boisseau MR, Drouet L. 1994. How does ticlopidine treatment lower plasma fibrinogen? Thromb Res. 75:361–370.
   PubMed Web of Science ®Google Scholar
• Pozzi A, Bernardo E, Coronado M, Punchard M, González P, Fantidis P. 2009. Acute arterial thrombosis in the absence of inflammation: the stress-related anti-inflammatory hormone ACTH participates in platelet-mediated thrombosis. Atherosclerosis. 204:79–84.
   PubMed Web of Science ®Google Scholar
• Price MJ. 2009. Bedside evaluation of thienopyridine antiplatelet therapy. Circulation. 119:2625–2632.
   PubMed Web of Science ®Google Scholar
• Rishniw M, Pion PD. 2011. Is treatment of feline hypertrophic cardiomyopathy based in science or faith? A survey of cardiologists and a literature search. J Feline Med Surg. 13:487–497.
   PubMed Web of Science ®Google Scholar
• Rush JE, Freeman LM, Fenollosa NK, Brown DJ. 2002. Population and survival characteristics of cats with hypertrophic cardiomyopathy: 260 cases (1990–1999). J Am Vet Med Assoc. 220:202–207.
   PubMed Web of Science ®Google Scholar
• Smith S, Tobias A. 2004. Feline arterial thromboembolism: an update. Vet Clin North Am Small Anim Pract. 34:1245–1271.
   PubMed Web of Science ®Google Scholar
• Storey RF. 2006. Biology and pharmacology of the platelet P2Y12 receptor. Curr Pharm Des. 12:1255–1259.
   PubMed Web of Science ®Google Scholar
• Sweeney JD, Hoernig LA, Michnik A, Fitzpatrick JE. 1989. Whole blood aggregometry. Influence of sample collection and delay in study performance on test results. Am J Clin Pathol. 92:676–679.
   PubMed Web of Science ®Google Scholar
• Thomas WP, Gaber CE, Jacobs GJ, Kaplan PM, Lombard CW, Moise NS, Moses BL. 1993. Recommendations for standards in transthoracic two-dimensional echocardiography in the dog and cat. Echocardiography Committee of the Specialty of Cardiology, American College of Veterinary Internal Medicine. J Vet Intern Med. 7:247–252.
   PubMed Web of Science ®Google Scholar
• van Werkum JW, Kleibeuker M, Postma S, Bouman HJ, Elsenberg EH, ten Berg JM, Hackeng CM. 2010. A comparison between the Plateletworks-assay and light transmittance aggregometry for monitoring the inhibitory effects of clopidogrel. Int J Cardiol. 140:123–126.
   PubMed Web of Science ®Google Scholar